- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
B3GNT4 Antibody (Center)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP10696c | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
| AP10696c-ev20 | Ev20 size 100 ul | In Stock | $ 95.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
B3GNT4 Antibody (Center) - Product info | |
| Application | WB, FC
|
| Primary Accession | Q9C0J1 |
| Other Accession | NP_110392.1 |
| Reactivity | Human, Mouse |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 42310 Da |
B3GNT4 Antibody (Center) - Additional info | |
| Gene ID 79369 | |
| Other Names B3GNT4; UDP-GlcNAc:betaGal beta-1, 3-N-acetylglucosaminyltransferase 4 | |
| Target/Specificity This B3GNT4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 236-264 amino acids from the Central region of human B3GNT4. | |
| Dilution WB~~1:100~500WB~~1:1000 FC~~1:10~50 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions B3GNT4 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures. | |
B3GNT4 Antibody (Center) - Protein Information | |
| Name B3GNT4 | |
| Function Has a beta-1,3-N-acetylglucosaminyltransferase activity for type 2 oligosaccharides | |
| Cellular Location Golgi apparatus membrane; Single-pass type II membrane protein (By similarity) | |
| Tissue Location Mainly expressed in brain tissues such as whole brain, hippocampus, amygdala, cerebellum and caudate nucleus. Also expressed in colon, esophagus and kidney | |
B3GNT4 Antibody (Center) - Related products
B3GNT4 Antibody (Center) - Application data
-
B3GNT4 Antaibody (Center) (Cat. #AP10696c) western blot analysis in HL-60 cell line lysates (35ug/lane).This demonstrates the B3GNT4 antibody detected the B3GNT4 protein (arrow).
-
B3GNT4 Antaibody (Center) (Cat. #AP10696c) western blot analysis in mouse liver tissue lysates (35ug/lane).This demonstrates the B3GNT4 antibody detected the B3GNT4 protein (arrow).
-
B3GNT4 Antibody (Center) (Cat. #AP10696c) flow cytometric analysis of HL-60 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
B3GNT4 Antibody (Center) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene encodes a member of the beta-1,3-N-acetylglucosaminyltransferase protein family. The encoded enzyme is involved in the biosynthesis of poly-N-acetyllactosamine chains and prefers lacto-N-neotetraose as a substrate. It is a type II transmembrane protein. [provided by RefSeq].
REFERENCES
Shiraishi, N., et al. J. Biol. Chem. 276(5):3498-3507(2001) Amado, M., et al. Biochim. Biophys. Acta 1473(1):35-53(1999)